Results 51 to 60 of about 10,594,499 (293)

Special Libraries, December 1924 [PDF]

open access: yes, 1924
Volume 15, Issue 10https://scholarworks.sjsu.edu/sla_sl_1924/1009/thumbnail ...
Special Libraries Association
core   +2 more sources

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

open access: yesMolecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung   +17 more
wiley   +1 more source

The Cowl - v.25 - n.17 - Nov 15, 1972 [PDF]

open access: yes, 1972
The Cowl - student newspaper of Providence College. Volume 25, Number 17 - November 15, 1972. 12 pages. Note: The volume number printed on the banner page of this issue (XXV) duplicates the volume number for 1962-63 academic ...

core   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon   +9 more
wiley   +1 more source

Front Cover and Publication Information, Volume 15 Number 1 [PDF]

open access: yes, 1982
Front cover and publication information, including a table of contents, for this ...

core   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

open access: yesMolecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang   +3 more
wiley   +1 more source

Table of Contents [PDF]

open access: yes, 2019
Table of contents for Volume 15, Issue 2 of the Linfield ...
Linfield Magazine Staff
core   +1 more source

The Cowl - v. 84 - n. 15 - Feb 6, 2020 [PDF]

open access: yes, 2020
The Cowl - student newspaper of Providence College. Volume 84 - Number 15 - February 6, 2020.

core   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

The Cowl - v.29 - n.11 - Sep 15, 1976 [PDF]

open access: yes, 1976
The Cowl - student newspaper of Providence College. Volume 29, Number 11 - September 15, 1976. 8 pages. Note: The volume number printed on the banner page of this issue (XXIX) duplicates the volume number for the 1966-67 academic ...

core   +1 more source

Home - About - Disclaimer - Privacy